Board of Directors:

Leadership & Experience

The Board for Stemina Biomarker Discovery advises the NeuroPointDX division and includes industry leaders with the business acumen and good judgment to lead us forward.

Scott Carr

CEO – Phoenix Technology Group

Heiner Dreismann, Ph.D.

Former President & CEO – Roche Molecular Systems; Global Head of Business Development – Roche Diagnostics

Elizabeth LR Donley, JD MBA MS

Chief Executive Officer

Andrew Ferrara

Chairman – Boston HealthCare

Kevin Krenitsky, MD

Former COO, CCO – Foundation Medicine

Andrew Morgan, R.Ph.

Executive Vice President, Regulatory Affairs & Quality Operations – Zurex Pharma

Marc Schneebaum

SVP & Chief Financial Officer, Madrigal Pharmaceuticals